Year: 2019
Type: article
Abstract: Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$4 billion, in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for wider adoption. We review the diversity of approaches and current progress made by national genomic-medicine initiatives in the UK, France, Australia, and US and provide a roadmap for sharing strategies, standards, and data internationally to accelerate implementation.
Institutions: The University of Melbourne, Murdoch Children's Research Institute, Australian Genomics Health Alliance, Ontario Institute for Cancer Research, National Institutes of Health, National Human Genome Research Institute, National Health Service, Queen Mary University of London, Genomics England, Inserm, Verily Life Sciences LLC (United States), Wellcome Sanger Institute, Queen's University Belfast, Macquarie University, European Bioinformatics Institute
Language: English
Topic: Genomics and Rare Diseases
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,000
OpenAlex ID: W2906821085